These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18326076)

  • 61. Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis.
    Patwardhan P; Landsteiner A; Lal LS; Geevarghese L; Le L; Nandal S; Cuker A
    Ann Hematol; 2022 Jan; 101(1):11-19. PubMed ID: 34505942
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report.
    Mendicino F; Santoro C; Martino E; Botta C; Baldacci E; Ferretti A; Muto B; Lucia E; Caracciolo D; Vigna E; Morelli M; Gentile M
    Blood Coagul Fibrinolysis; 2021 Oct; 32(7):519-521. PubMed ID: 34520405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroids.
    Wong TF; Majewska R; Tomiyama Y
    Int J Hematol; 2021 Aug; 114(2):152-163. PubMed ID: 33851348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Eltrombopag for chronic immune thrombocytopenia.
    Tanimoto T; Fukunaga S; Hori A; Yagasaki F; Ono S
    Lancet; 2011 Jun; 377(9781):1919; author reply 1919-20. PubMed ID: 21641478
    [No Abstract]   [Full Text] [Related]  

  • 65. Thrombopoietin-receptor agonists for primary immune thrombocytopenia.
    Imbach P; Crowther M
    N Engl J Med; 2011 Aug; 365(8):734-41. PubMed ID: 21864167
    [No Abstract]   [Full Text] [Related]  

  • 66. Update on eltrombopag for ITP.
    Bussel JB
    Oncology (Williston Park); 2009 Nov; 23(13):1177-8. PubMed ID: 20043469
    [No Abstract]   [Full Text] [Related]  

  • 67. Cardiac and pulmonary thrombosis during multidrug treatment in an idiopathic thrombocytopenic purpura patient.
    Andic N; Gunduz E; Akay OM; Şahin D; Teke HÜ
    Platelets; 2014; 25(1):69-70. PubMed ID: 23320868
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.
    Jolliffe E; Romeril K
    Intern Med J; 2014 Jul; 44(7):697-9. PubMed ID: 25041772
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Retrospective analysis of eltrombopag for the treatment of refractory primary immune thrombocytopenia in Japan].
    Yoshida M; Kanashima H; Nakao T; Ogawa Y; Hino M; Nakane T; Ohta T; Kumura T; Manabe M; Yamamura R; Yamane T
    Rinsho Ketsueki; 2013 May; 54(5):444-50. PubMed ID: 23727682
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successful eltrombopag treatment of refractory idiopathic thrombocytopenic purpura associated with Crohn disease.
    El Rassy E; Kourie HR; Nehme W; Georges S; Haddad E; Nasnas R; Nasr F
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e23-4. PubMed ID: 25497274
    [No Abstract]   [Full Text] [Related]  

  • 71. Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis.
    Ahmed HAW; Masoud AT; Han J; Adel Sofy A; Saeed Ahmed A; Abdesattart AT; Drokow EK; Sun K
    Clin Appl Thromb Hemost; 2021; 27():10760296211005555. PubMed ID: 33874785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpura.
    Noronha V; Philip SD; Joshi A; Prabhash K
    Int J Hematol; 2012 Sep; 96(3):380-2. PubMed ID: 22851056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Lisman T; Porte RJ
    N Engl J Med; 2012 Nov; 367(21):2055-6. PubMed ID: 23171114
    [No Abstract]   [Full Text] [Related]  

  • 74. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Violi F; Pignatelli P
    N Engl J Med; 2012 Nov; 367(21):2056. PubMed ID: 23171115
    [No Abstract]   [Full Text] [Related]  

  • 75. Boosting platelet production.
    Wei A; Jackson SP
    Nat Med; 2008 Sep; 14(9):917-8. PubMed ID: 18776883
    [No Abstract]   [Full Text] [Related]  

  • 76. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
    Kuter DJ
    Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).
    Cela I; Miller IJ; Katz RS; Rizman A; Shammo JM
    Clin Adv Hematol Oncol; 2010 Nov; 8(11):806-9. PubMed ID: 21326158
    [No Abstract]   [Full Text] [Related]  

  • 78. An escalating treatment strategy for children with severe chronic immune thrombocytopenia: Preliminary report from a single center.
    Fu L; Ma J; Gu H; Ma J; Wei Y; Chen Z; Wu R
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29006. PubMed ID: 33720524
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
    Gauchan D; Shaaban H; Gedeon D; Maroules M
    Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
    [No Abstract]   [Full Text] [Related]  

  • 80. Eltrombopag with i.v. immunoglobulin for safe splenectomy in refractory immune thrombocytopenia.
    Kanno M; Onoda T; Meguro T; Sato H; Mitsui T
    Pediatr Int; 2018 Feb; 60(2):191-192. PubMed ID: 29271533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.